AI Article Synopsis
- Motor neurone disease (MND) causes significant symptom burden among patients, but there's limited understanding of their specific needs and experiences, especially among palliative care providers.
- This study evaluated 102 MND patients, revealing they reported a median of 17 symptoms, with motor and functional issues being the most common; severe symptoms were notably higher in those receiving palliative care and those near end-of-life.
- The findings suggest the need for a specialized assessment tool for MND symptoms and further research to develop effective treatment guidelines tailored to the unique symptom profiles of these patients.*
Article Abstract
Background: Motor neurone disease is a rare but debilitating illness with incomplete evidence regarding patients' symptom burden. Palliative care and generalist clinicians are often in-experienced in caring for these patients and assessing their needs.
Aim: To identify the symptom prevalence and severity experienced by patients with motor neurone disease. Secondary objectives were to examine differences in symptom burden and clusters according to phenotype, functional status, palliative care provision and those in their last months of life.
Design: A point prevalence study assessing patient-reported symptoms using a modified IPOS-Neuro assessment tool, incorporating 41 symptom items.
Setting/participants: Patients with motor neurone disease attending the State-wide Progressive Neurological Disease Service or inpatient unit at Calvary Health Care Bethlehem, Melbourne Australia, from March to December 2021.
Results: A total of 102 patients participated, the majority diagnosed with lumber-onset (30.4%), bulbar-onset (28.4%) and cervical-onset (25.5%) phenotypes. Patients experienced a median of 17 symptoms (range 2-32) with a median of 3 symptoms rated as severe/overwhelming (range 0-13). Motor and functional symptoms predominated, with differences in symptom clusters present according to phenotype. Patients had a higher number of severe/overwhelming symptoms if they were accessing palliative care services ( = 0.005), in their last 6 months of life ( = 0.003) and experiencing moderate or severe functional impairment ( < 0.001).
Conclusions: Patients with motor neurone disease report high symptom burden. A validated motor neurone disease-specific symptom assessment tool is needed to accurately assess patients, including important variations in symptom clusters according to phenotype. Further research must focus on evidence-based treatment guidelines for symptoms experienced commonly and severely.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/02692163231191545 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!